chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she had no reaction with the first or second vaccine but did have a headache with all the vaccines; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old female patient received BNT162b2 (BNT162B2), on 23Jan2021 as dose 1, single (Lot number: EL9261), in left arm and on 13Feb2021 as dose 2, single (Lot number: EM9809) at the age of 80 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Mantle cell lymphoma" (unspecified if ongoing), notes: Mantle cell lymphoma in remission for 5 years; "Colon cancer" (unspecified if ongoing), notes: Colon cancer in remission for 5 years; "Aortic valve replacement", start date: 02Mar2015 (unspecified if ongoing); "her husband had lung cancer, he passed away" (unspecified if ongoing). The patient's family history included: "aortic valve replacement" (unspecified if ongoing), notes: her other daughter had an aortic valve replacement and her sister; "her son had a lung transplant" (unspecified if ongoing), notes: he was 61 years old; "Her daughter is diabetic" (unspecified if ongoing); "COPD" (unspecified if ongoing), notes: Her son had a lung transplant from COPD. There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "she had no reaction with the first or second vaccine but did have a headache with all the vaccines". Therapeutic measures were not taken as a result of headache.  Additional information: The patient later had the booster of BNT162b2 on 02Sep2021, as dose 2, single (Lot number: FC3184) at the age of 80 years, in left upper arm for covid-19 immunisation and the next day her arm swelled up from the injection site to her elbow. It was warm and itchy, headache.  Follow-Up (13Apr2022): Follow-up attempts are completed. No further information is expected.
Patient recieved vaccine - after 30min she experience swollen throat. She did not have shortness of breath. Per patient caregiver (mother) patient complained of swollen throate. Patient was then given Childrens benadryl and told to go to ER.
After my Pfizer  COVID - 19 vaccination  on  09/14/2022.   I was diagnosed with two types of Lymphoma Diffuse Large B Cell  and  Lymphoplasmacytic with Waldenstrom's . My physician feels the vaccination may have triggered the Lymphoma and I felt the need to report the information.
Intensely itchy skin, hives and dermatographia. Started 10 days after booster on 11/22/21. Controlled with Allegra, Pepcid, Zyrtec but still unable to wean off antihistamines to date.
30DEC92 @ 4AM began crying; over next 12 hrs cried intermittently & feeds poorly; when examined 30DEC92 had stopped crying;
For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022; Expired doses of Moderna COVID-19 were administered beyond the beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date) and PRODUCT STORAGE ERROR (For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date) and PRODUCT STORAGE ERROR (For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter  Patient took 2nd booster dose of Moderna and took total 4 doses. Lot number 083J21A was refrigerated on 7-Feb-2022. Vial did not undergo any temperature excursion  No treatment medication was reported by reporter.
Mother reports that child had vomiting and diarrhea in middle of the night and still has diarrhea today. 3/9/05 diarrhea stopped at 9:30 3/8/05. Vomiting stopped 5:30 am 3/8/05. No one in family has become ill. Child is normal today.
Initial report received from a healthcare professional on 22 January 2014. A 64-year-old female patient had received a dose of FLUZONE ID (Batch number: UT4721AA, expiry date: 08 April 2014, dose number was not reported) on 05 November 2013. Patient had no illness at the time of vaccination. The patient is allergic to BISCODYL, EFFEXOR, LEXAPRO. On 06 November 2013, the patient developed knot at the vaccination site. Corrective treatments and laboratory investigations were not reported. At the time of this report, the patient had not recovered from the event. Documents held by sender none.
STARTED SWEATING,  BECAME HOT, AND STARTED TURNING RED ON HER NECK AND FACE---LASTED ABOUT 3 MINUTES BENADRYL 50MG GIVEN PO.
Confused; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confused) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced CONFUSIONAL STATE (Confused). At the time of the report, CONFUSIONAL STATE (Confused) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided.  No treatment details were provided.    This case was linked to MOD-2021-029441 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: TCR
2hrs post vax administered, high-pitched cry started, continous x 3 hrs; Child taken to ER, parent advised to push fluids & continue w/APAP;
This spontaneous report as received from a medical assistant refers to an unspecified amount of patients (demographics unknown). Pertinent medical history, drug allergies or reactions were not reported. On unknown dates, the patients were vaccinated with doses of ZOSTAVAX (dose, lot numbers and route were not reported) that underwent temperature excursions. Concomitant medication was not reported. No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
This spontaneous report was received from an unidentified caller and refers to a 9-month-old patient of unkonwn gender. The patient's medical history, concurrent conditions, drug reactions and allergies were not reported. The reporter stated that on an unknown date, the patient received a dose of ROTATEQ (dose, lot# and expiration date were not reported; route of administration defaulted to oral). No adverse effects were reported. Additional information is not expected, no contact details were provided.
I had flu like symptoms and my arthritis flare up. I required Prednisone.
Chills and Shaking,   Fever up to 103 degrees.  Called Clinic & they had me change from Advil to Tylenol  &  to come in if it didn't come down.  Came down to 102.    Achy & Tired.  Head felt like I had a cold.   Next 2 days ran fever between 99.9-100.0.
COVID 19; COVID 19;This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 33-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Jan2021 at 14:00 as dose 1, single (Lot number: EL8982), in left arm and on 09Feb2021 at 14:00 as dose 2, single (Lot number: EM9810) at the age of 32 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 08Nov2021 at 22:00 as dose 3 (booster), single (Lot number: 033F21A), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: PRENATAL MULTIVITAMIN + DHA, start date: 01Mar2022, stop date: 20May2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information in the case, an association between the reported events and the suspect product BNT162B2 cannot be ruled out.
Information regarding Flumist nasal solution was received from a consumer regarding his 29 year old wife who experienced diarrhea, sore throat and stuffy nose. At 29 years of age, she received a dose on 12/15/03. She had no relevant medical history. Indication for Flumist was immunization. Product was administered on 12/15/03. Dose regimen was 1 dose (IN). She was not taking concomitant therapy. On 12/16/03, she experienced diarrhea, sore throat, and stuffy nose. No additional information was available at the time of this report.
ED and based on symptoms of diaphoresis and increased drainage from incisional site, he was deemed appropriate for admission to neurosurgery service to rule out abscess/spinal infection vs COVID
G47.33 OBSTRUCTIVE SLEEP APNEA 4/13/2023 SEVERE OBESITY, BMI 40-44.9, ADULT
Information has been received from a medical assistant concerning a three elementary school aged patient about the age of 8 or 9 who received the second dose of VARIVAX (Merck) (lot # "0996 Y or X") on the same day the patient developed a raised knot, reddened area and about three inches in diameter.  The onset of the symptoms was not specified.  The symptoms resolved in an unspecified period of time.  No other symptoms or treatment reported.  Follow-up information was received from a medical assistant who identified one of the patients as a 7 year old female patient who received the second dose of VARIVAX (Merck).  The medical assistant reported that she could not remember any other information regarding the patient.  This is one of several reports received from the same source.  Additional information has been requested.
2 weeks after the 2nd shot I woke up with a pain going from my left armpit, along my collarbone to my neck under my jawline. It felt like a string from my armpit to my neck was too  short and tight. I also felt slightly ill with pain behind my eyes for the 1st 2 weeks when pain began. I assumed it was my lymph nodes on my l eft side that was affected and not a muscle issue since rubbing it made it hurt more. By the 3rd week I was able to go back to swimming and other activities. It's 8 weeks now but still slightly tender on collarbone and neck.
Narrative:  99yo male patient was discharged home from inpatient admission for Peripheral Vascular Disease. Patient with a h/o advanced dementia, osteoarthritis, PVD, right femoral artery stenosis, and 2nd toe dry gangrene and osteomyelitis. Pt had received covid vaccines on 1/29/21, 2/26/21, & 11/9/21. Pt died at home on 12/28/2021. Likely Death is not related to covid vaccines given patient's comorbidities, advanced age, and length of time from vaccine administration.
Patient was given Fluzone vaccine for ages 65 and older.  Patient is only 64 years old. No adverse reactions occurred after injection.  Patient and her MD were made aware of the error. Patient was observed for greater than 30 minutes after vaccine administered.
Pfizer vaccine administered after the 12 hour expiratory time. Approximately 24 hours past expiration time. No adverse event reported.
Approximately nine hours after second dose, I began to feel as if a flu was coming on. Shortly after upon falling asleep, I started getting the chills and felt as though I had a fever. Waking up in the morning, I had a painful throbbing headache. My muscles ached and I felt very fatigued. I was unable to get out of bed due to said fatigue. I felt as though I had a temperature, but did not take it at that juncture. I had no appetite. When I did manage to stand, the headache would throb and I felt nauseated. Later that evening, I had a slight fever of 100.8 degrees fahrenheit. The following morning, I felt nearly recovered, but my head would still throb when changing positions, but not with the same severity as the previous day. Headache slightly persists to this day.
Patient called pharmacy at approximately 9:30 am on the day following administration of vaccine and states that she has developed redness and swelling at the injection site approximately the size of a quarter. Patient was advised to take ibuprofen 200mg and apply ice/cold compress to the area. Patient states there is no other rash, no blisters or open skin at injection site.  Pharmacist called patient at 2:15pm to check on her status and patient states that it has resolved for the most part and she is unconcerned at this time.
Had this 24 hours after first vaccine and again with second. Didnt report first time but did notify my department manager and OR educator.  Bloody nose, dripping like a runny nose. Last 3 days after first vaccine. Just starting again with second vaccine. Not as severe but still bloody when I blow it.
Information has been received from a healthcare worker concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 15-MAY-2015, the patient was vaccinated with a dose of improperly stored (Oka-Merck) PROQUAD, lot # L002419, expiration date 30-APR-2016 (dose and route not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because the physician did not wish to be contacted.
58-year old female presents with 1 day(s) of moderate trauma skin ( bruises, cuts, and scrapes) that is worsening. Patient has associated edema (and ecchymosis anteromedial right lower leg mid leg to ankle). Patient denies limited range of motion, and fever greater than 100.4.  Patient had Pfizer vaccinations finished about 4 weeks ago. Last week carrying package under right arm and developed ecchymosis. Yesterday hit right anterior leg with wet air of pants doing laundry and developed swelling and ecchymosis of left medial anterior leg. States has history of easy bruising. Also is pharmacy tech given COVID-19 vaccinations. Recently stuck finger with clean needle and bleed for quite some time.
Patient developed SOB 2/10/2021 and was diagnosed with PE/DVT at a local hospital
under diluted dose given. chills, vomiting, dizzy, headache-symptoms resolved as of 07/28/21
Sore; arm is itchy; Hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore), PRURITUS (arm is itchy) and VACCINATION SITE WARMTH (Hot to touch) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (Sore), PRURITUS (arm is itchy) and VACCINATION SITE WARMTH (Hot to touch). At the time of the report, PAIN (Sore), PRURITUS (arm is itchy) and VACCINATION SITE WARMTH (Hot to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Information has been received from a consumer concerning her approximately 24 month old son who on an unspecified date was vaccinated with the first dose of MMR II (lot # not provided) at the age to 24 months. The patient was diagnosed with autism after getting the first dose. The patient never received the booster dose. The consumer also mentioned that when her son was 5 years old he was administered with DTaP (unspecified) (+) DPT (manufacturer unspecified) he developed aggressive behavior. At the time of this report, the outcome was not provided. Unspecified medical attention was sought. Upon internal review, autism was considered to be other important medical event. This is one of several reports received from the same source. No further information is available.
temperature excursion for the following unopen products: QUADRACEL, DAPTACEL, PENTACEL, and TUBERSOL with no reported adverse event; Initial information received on 10-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient with unknown demographics who had temperature excursion for the following unopen products: quadracel, daptacel, pentacel, and tubersol with no reported adverse event while receiving vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL], DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] and DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] and while treated with TUBERCULIN PPD [TUBERSOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient started taking TUBERSOL (TUBERCULIN PPD) Unknown dosage unknown route unknown (lot - C5735AA). On an unknown date, the patient received a  dose of suspect DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE lot C5862BA via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5816AA via unknown route in unknown administration site. On an unknown date, the patient received a  dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot UJ597AAA in unknown administration site.  On 07-JAN-2022 the patient had a non-serious temperature excursion for the following unopen products: quadracel, daptacel, pentacel, and tubersol with no reported adverse event (product temperature excursion issue) (unknown latency) following the administration of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (temperature excursion for the following unopen products: QUADRACEL, DAPTACEL, PENTACEL, and TUBERSOL with no reported adverse event).  At time of reporting, the outcome was Unknown for the event temperature excursion for the following unopen products: quadracel, daptacel, pentacel, and tubersol with no reported adverse event.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. The patient's pertinent medical history and concurrent condition were not reported. On 11-AUG-2015, the patient was vaccinated with improperly stored dose of PROQUAD (Merck) (lot # K021548, expiration date 06-MAY-2016, dose, frequency and route were unknown). No concomitant medication was reported. No adverse effects reported. No product quality complaint (PQC) was involved. This is one of several reports from the same reporter. Additional information has been requested.
SWOLLEN INJECTION SITE THAT RADIATED TO ELBOW, FEVER (UNKNOWN TEMP) PATIENT STATES SHE TOOK TYLENOL, SYMPTOMS LASTED FOR 2 WEEKS. PATIENT STATES SHE IS WELL NOW. ALL SYMPTOMS HAVE SUBSIDED.
It was reported that a female pt received Rabies Imovax IM vaccine on 7/2/99. Reportedly, that same day, the pt experienced tingling, numbness in right leg and stiff neck for 12 hours. Resolved without medical intervention. From additional information received on 7/27/99, it was reported, "With subsequent vaccines, it seemed to last a bit longer. Vaccine brand was changed for #4 and #5 (RabAvort) and had less tingling."
injected in the wrong area; He says in the joint he can feel it in there; under his arm pit down kind of close to his rib cage.; Shoulder Injury Related to Vaccine Administration; inflammation in the shoulder joint; history of shoulder pain because of arthritis, but it wasn't bothering him until after he got the vaccine; bad shoulder and arm pain; bad shoulder and arm pain; This is a spontaneous report from a contactable consumer. This 69-year-old Male consumer (patient, reported for self). A 69-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0161, Expiration date: Unknown), via an unspecified route of administration, administered in Arm Left on 06Jul2021 as (At the age of 69-years) dose 1, single for COVID-19 immunisation. Medical history included arthritis (shoulder pain because of arthritis) from an unknown date and unknown if ongoing. There were no concomitant medications reported by the reporter (Other Products: No). It was reported that on 06Jul2021 around between 1:00PM to 1:30PM parient received the first dose. Reporter stated that it was after this vaccination, that the pain began a couple days after that he had bad shoulder and arm pain. He says this started a couple days after that and it has not gone away or gotten any better. Reporter stated his pain is in the shoulder and arms closer to his elbow, and under his arm pit down kind of close to his rib cage. He says in the joint he can feel it in there. It was reported that he has a history of shoulder pain because of arthritis, but it wasn't bothering him until after he got the vaccine. Upon Follow-up it was reported that reporter was 70 years old but noted that he was 69 when he got the Pfizer- BioNTech COVID-19 Vaccine. The reporter state that bad shoulder and arm pain has not gone away and not gotten better. His main concern was having Shoulder Injury Related to Vaccine Administration (SIRVA) an injury and inflammation in the shoulder joint due to the vaccine being injected in the wrong area. Reporter hung up before survey could be offered. No investigation assessment. Reporter stated he was currently taking medication for pain, Hydrocodone, which came in an orange pill bottle. He says the Hydrocodone dose is 7.5-325mg, and it comes from (Place name withheld) Home RX in (redacted). Hydrocodone LOT/EXP: Unknown, product dispensed in pharmacy bottle. Hydrocodone NDC: 65162-0115-11. He says he takes this once every 6 hours.  The outcome of event bad shoulder and arm pain had not recovered, outcome of other events was unknown.  Follow-up attempts are completed. No further information is expected.
I have an area that is 3.5 x 3.5, it's red, its itchy and sore and very painful. It's swollen. It's like a baseball on my arm. Yesterday, only, on May, 24, 2023,  I felt feverish. The site is hot to the touch. I didnt take my temp, but I felt feverish. I took tylenol and a cold pack on my arm. Really no outcome, cause it stayed the same.
Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Slight fever). At the time of the report, PYREXIA (Slight fever) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided.